Armonair Respiclick (fluticasone propionate MDPI) / Teva  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Armonair Respiclick (fluticasone propionate MDPI) / Teva
NCT02175771: Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Completed
3
758
US
Fp MDPI, fluticasone propionate, inhaled corticosteroid, FS MDPI, Salmeterol xinafoate, β2 adrenoceptor agonist, FLOVENT HFA, ADVAIR DISKUS, salmeterol xinafoate, albuterol/salbutamol HFA, ProAir HFA, short-acting β2-adrenergic agonists
Teva Branded Pharmaceutical Products R&D, Inc.
Persistent Asthma
07/15
07/15
NCT02139644 / 2014-001149-25: Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

Completed
3
787
Europe, Canada, US, RoW
FS MDPI, fluticasone propionate, inhaled corticosteroid, salmeterol xinafoate, β2 adrenoceptor agonist, Fp MDPI, Placebo MDPI, inert powder, albuterol/salbutamol, short-acting β2-adrenergic agonists, Beclomethasone dipropionate, QVAR
Teva Branded Pharmaceutical Products R&D, Inc.
Asthma
09/15
09/15
NCT02141854 / 2014-000923-25: Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

Completed
3
882
Europe, Canada, US, RoW
FS MDPI, fluticasone propionate, inhaled corticosteroid, salmeterol xinafoate, β2 adrenoceptor agonist, Fp MDPI, Placebo MDPI, inert powder, Albuterol/salmeterol HFA MDI, short-acting β2-adrenergic agonists
Teva Branded Pharmaceutical Products R&D, Inc.
Asthma
09/15
09/15
NCT02980133 / 2016-003835-39: Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Completed
3
841
Europe, US, RoW
Fluticasone Propionate, Fluticasone Propionate/Salmeterol, Placebo MDPI
Teva Branded Pharmaceutical Products R&D, Inc.
Asthma
04/19
04/19

Download Options